03/31/2025
TimiHealth Was Right All Along — The 23andMe Collapse Validates Its Core Vision of Data Ownership, Privacy, and Ethical Tech
In 2018, TimiCoin/TimiHealth issued a bold public challenge: consumers should demand full control over their genetic data from companies like 23andMe. The message was clear, urgent, and—at the time—largely ignored by mainstream media and industry insiders.
But in 2025, with 23andMe filing for bankruptcy and over 14 million users’ genetic data now potentially exposed, TimiHealth’s vision has been undeniably, powerfully validated.
⸻
1. TimiHealth Saw It Coming
In its original release, TimiHealth urged:
“Petition 23andMe and other genetic testing companies and demand ownership and control of their genetic data.”
The model 23andMe built—centralized, corporate-owned, and profit-first—has now imploded under the weight of that very risk. Read the original warning here:
https://www.biospace.com/article/releases/timicoin-timihealth-urges-consumers-to-petition-23andme-and-other-genetic-testing-companies-and-demand-ownership-and-control-of-their-genetic-data/
And the bankruptcy confirmation here:
https://nypost.com/2025/03/24/business/dna-firm-23andme-files-for-bankruptcy/
⸻
2. Consent Was Always the Ethical Flashpoint
TimiHealth argued early on that:
“Genetic data is the most personal information a person has, and it must remain in the control of the individual.”
Now, California Attorney General Rob Bonta has issued a public alert recommending that users delete their genetic data and request destruction of DNA samples due to privacy concerns in the wake of 23andMe’s bankruptcy.
Follow that story here:
https://www.cnbc.com/2025/03/23/23andme-bankruptcy-filing-triggers-dna-privacy-concerns.html
⸻
3. TimiHealth Offered a Safer, Smarter Model
Instead of selling data access, TimiHealth developed a blockchain-powered platform based on:
• Encrypted, user-controlled data storage
• Smart contracts for managing access
• Tokenized incentives for sharing—only when and if users chose to
This wasn’t just innovative—it was protective. A proactive answer to the exact problem now making headlines.
⸻
4. Regulators Are Still Behind
TimiHealth warned of this too: that regulation would lag behind innovation, and users would be the ones paying the price. That’s exactly what’s happening. In 2025, regulators are now scrambling to contain a crisis that was entirely preventable.
Read the AP coverage on the regulatory scramble:
https://apnews.com/article/0b36b01fa86073e5ae602ab8a7d0a628
⸻
5. A Vision Proved Right—Just Ahead of Its Time
The market in 2018 may not have been ready for what TimiHealth built. But the past few weeks and months have made one thing crystal clear: the founding vision of TimiHealth—decentralized, privacy-first, consumer-empowered health data—isn’t just relevant.
It’s necessary.
⸻
Conclusion: The Small Group That Got It Right
While the industry chased valuations and data monetization, a small group of visionaries behind TimiHealth stood firm on principle: that individuals—not corporations—should own and control their biological identity.
In 2025, their foresight is no longer radical. It’s reality.
The warnings were there. The solution was built. The future belongs to those who saw the cracks before the collapse.
23andMe has filed for bankruptcy, prompting people who've used the service and sent in DNA samples to be analyzed to wonder what will happen to their genetic data.
